Page last updated: 2024-11-03

propafenone and Tachycardia, Ventricular

propafenone has been researched along with Tachycardia, Ventricular in 43 studies

Propafenone: An antiarrhythmia agent that is particularly effective in ventricular arrhythmias. It also has weak beta-blocking activity.
propafenone : An aromatic ketone that is 3-(propylamino)propane-1,2-diol in which the hydrogen of the primary hydroxy group is replaced by a 2-(3-phenylpropanoyl)phenyl group. It is a class 1C antiarrhythmic drug with local anesthetic effects, and is used as the hydrochloride salt in the management of supraventricular and ventricular arrhythmias.

Tachycardia, Ventricular: An abnormally rapid ventricular rhythm usually in excess of 150 beats per minute. It is generated within the ventricle below the BUNDLE OF HIS, either as autonomic impulse formation or reentrant impulse conduction. Depending on the etiology, onset of ventricular tachycardia can be paroxysmal (sudden) or nonparoxysmal, its wide QRS complexes can be uniform or polymorphic, and the ventricular beating may be independent of the atrial beating (AV dissociation).

Research Excerpts

ExcerptRelevanceReference
"Our objective was to evaluate the efficacy and safety of intravenous (IV) sotalol in the treatment of incessant tachyarrhythmias in children with normal cardiac function."7.85Efficacy of Intravenous Sotalol for Treatment of Incessant Tachyarrhythmias in Children. ( Ge, H; Jiang, H; Li, X; Liu, H; Zhang, Y, 2017)
"Previous bradyarrhythmias or sick sinus syndrome (SSS), and concomitant use of antiarrhythmic drugs were exclusion criteria."6.68Conversion of recent onset atrial fibrillation with single loading oral dose of propafenone: is in-hospital admission absolutely necessary? ( Alfieri, G; Barone, P; Bernasconi, G; Bonini, W; Botto, GL; Broffoni, T; Ferrari, G; Lombardi, R; Molteni, S, 1996)
"No sustained ventricular tachycardia, ventricular fibrillation, sudden cardiac death, or cardiovascular mortality were observed."5.72Propafenone use in coronary artery disease patients undergoing atrial fibrillation ablation. ( Aksu, T; Aras, D; Cay, S; Kara, M; Ozcan, F; Ozeke, O; Topaloglu, S, 2022)
"Spontaneous monomorphic and polymorphic ventricular tachycardias (VT) were observed during monitoring."5.33Monomorphic and propafenone-induced polymorphic ventricular tachycardia in Brugada syndrome: a case report. ( Dinckal, MH; Karaca, M, 2006)
"Propafenone is an antiarrhythmic drug used in the treatment of life-threatening ventricular tachyarrhythmias."5.30Propafenone-induced drug fever in the absence of agranulocytosis. ( Gerling, BR; Greenberg, ML; Holzberger, PT; O'Rourke, DJ; Palac, RT, 1997)
" Dosage and serum levels of propafenone did not differ whether the patients were treated successfully or not."5.29Clinical experience with propafenone for cardiac arrhythmias in the young. ( Bourgeous, M; Heusch, A; Kramer, HH; Krogmann, ON; Rammos, S, 1994)
" In 1987, the Cardiac Arrest Study Hamburg (CASH), a prospective, randomized trial, was initiated to compare metoprolol, amiodarone, propafenone, and ICD implantation in patients surviving sudden cardiac death due to documented ventricular tachycardia and/or ventricular fibrillation."5.07Preliminary results of the Cardiac Arrest Study Hamburg (CASH). CASH Investigators. ( Cappato, R; Kuck, KH; Rüppel, R; Schneider, MA; Siebels, J, 1993)
"Our objective was to evaluate the efficacy and safety of intravenous (IV) sotalol in the treatment of incessant tachyarrhythmias in children with normal cardiac function."3.85Efficacy of Intravenous Sotalol for Treatment of Incessant Tachyarrhythmias in Children. ( Ge, H; Jiang, H; Li, X; Liu, H; Zhang, Y, 2017)
"Ventricular arrhythmia (VA) can occur during propafenone therapy in atrial fibrillation (AF) patients with structurally normal heart."3.81Factors predisposing to ventricular proarrhythmia during antiarrhythmic drug therapy for atrial fibrillation in patients with structurally normal heart. ( Chang, SL; Chang, Y; Chao, TF; Chen, SA; Chen, YY; Chien, KL; Chiou, CW; Chong, E; Chung, FP; Hu, YF; Liao, JN; Lin, CY; Lin, YJ; Lo, LW; Tuan, TC, 2015)
"The electrophysiological effects of combination therapy of mexiletine and propafenone were assessed using standard 12-lead electrocardiogram (standard ECG), signal-averaged ECG (SAECG), and ambulatory ECG in 31 patients with ventricular arrhythmias."3.68Mexiletine and propafenone: a comparative study of monotherapy, low, and full dose combination therapy. ( Haruna, M; Kato, H; Lee, S; Machii, T; Nonokawa, M; Takanaka, C; Yabe, S, 1992)
" Despite careful precautions, serious proarrhythmias, the major limiting side effect of dofetilide, still occurred during long-term follow-up."2.73Observations on the safety and effectiveness of dofetilide in patients with paroxysmal atrial fibrillation and normal left ventricular function. ( Bauman, JL; Kehoe, RF; Leal, S; Mykytsey, A; Razminia, M; Saleem, M; Wang, T; Zheutlin, T, 2007)
" After a period of placebo administration, all patients underwent three consecutive periods during which they received Pr IR at the dosage of 150 mg x 3, Pr SR at the dosage of 225 mg x 2, Pr SR at the dosage of 325 mg x 2."2.69[Double-blind randomized placebo-controlled study of the effects of slow release and immediate release forms of propafenone in patients ventricular extrasystole symptoms]. ( Massari, F; Mastropasqua, F; Pitzalis, MV; Rizzon, P; Totaro, P, 1998)
"Previous bradyarrhythmias or sick sinus syndrome (SSS), and concomitant use of antiarrhythmic drugs were exclusion criteria."2.68Conversion of recent onset atrial fibrillation with single loading oral dose of propafenone: is in-hospital admission absolutely necessary? ( Alfieri, G; Barone, P; Bernasconi, G; Bonini, W; Botto, GL; Broffoni, T; Ferrari, G; Lombardi, R; Molteni, S, 1996)
" The dosage from 50 to 100 mg/day made no difference."2.68Preliminary study of the effects of metoprolol and propafenone on ventricular arrhythmia with positive ventricular late potential. ( Duan, Y; Gao, E; Li, H; Yang, C; Zhou, Y, 1997)
"Overall efficacy of ventricular tachycardia pace termination was 69% and the time required to stop ventricular tachycardia was 14."2.67Randomized cross-over evaluation of two adaptive pacing algorithms for the termination of ventricular tachycardia. ( Green, MS; Kantoch, MJ; Tang, AS, 1993)
"In 1987, the Cardiac Arrest Study Hamburg (CASH), a prospective, multicenter, randomized controlled study, was started in survivors of sudden cardiac death resulting from documented ventricular tachyarrhythmias."2.67Implantable cardioverter defibrillator compared with antiarrhythmic drug treatment in cardiac arrest survivors (the Cardiac Arrest Study Hamburg). ( Kuck, KH; Siebels, J, 1994)
"Amiodarone has a more favourable therapeutic profile than flecainide and propafenone in these patients, having less tendency to worsen heart failure."2.67A multicentre, randomized trial on the benefit/risk profile of amiodarone, flecainide and propafenone in patients with cardiac disease and complex ventricular arrhythmias. Antiarrhythmic Drug Evaluation Group (A.D.E.G.). ( , 1992)
"Procainamide is effective for stable ventricular tachycardia, and amiodarone is effective in the treatment of shock-refractory ventricular fibrillation."2.41Intravenous antiarrhythmic agents. ( Dorian, P; Pinter, A, 2001)
"No sustained ventricular tachycardia, ventricular fibrillation, sudden cardiac death, or cardiovascular mortality were observed."1.72Propafenone use in coronary artery disease patients undergoing atrial fibrillation ablation. ( Aksu, T; Aras, D; Cay, S; Kara, M; Ozcan, F; Ozeke, O; Topaloglu, S, 2022)
"Propafenone is a class 1C antiarrhythmic drug used in the second-line management of supraventricular and ventricular arrhythmias and, when unintentionally ingested, can lead to severe and life-threatening poisoning."1.51Ventricular Tachycardia Induced by Propafenone Intoxication in a Pediatric Patient. ( Di Mita, O; DʼAnna, C; Marzuillo, P; Pappacoda, S; Ponticiello, E; Rosa, M; Tipo, V, 2019)
"Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a rare but potentially lethal inherited arrhythmia syndrome induced by adrenergic stress."1.48A delayed diagnosis of catecholaminergic polymorphic ventricular tachycardia with a mutant of RYR2 at c.7580T>G for 6 years in a 9-year-old child. ( Duan, H; Hua, Y; Li, Y; Lu, Y; Qiao, L; Wang, C; Yan, S; Zhou, K, 2018)
"Catecholaminergic polymorphic ventricular tachycardia (CPVT) is caused by mutations in the cardiac ryanodine receptor (RyR2) or calsequestrin (Casq2) and can be difficult to treat."1.37Inhibition of cardiac Ca2+ release channels (RyR2) determines efficacy of class I antiarrhythmic drugs in catecholaminergic polymorphic ventricular tachycardia. ( Faggioni, M; Hasdemir, C; Hwang, HS; Knollmann, BC; Laver, D; Mehra, D; Turhan, K; Yin, H, 2011)
"Propafenone was stereoselective, with R-propafenone suppressing waves more potently than S-propafenone (IC(50): R-propafenone 2 ± 0."1.37Efficacy and potency of class I antiarrhythmic drugs for suppression of Ca2+ waves in permeabilized myocytes lacking calsequestrin. ( Galimberti, ES; Knollmann, BC, 2011)
"Electrocardiography (ECG) showed ventricular tachycardia."1.35A case of myotonic dystrophy presenting with ventricular tachycardia and atrial fibrillation. ( Eroğlu, S; Müderrisoğlu, H; Ozbiçer, S; Ozin, B, 2009)
"Spontaneous monomorphic and polymorphic ventricular tachycardias (VT) were observed during monitoring."1.33Monomorphic and propafenone-induced polymorphic ventricular tachycardia in Brugada syndrome: a case report. ( Dinckal, MH; Karaca, M, 2006)
"Propafenone is an antiarrhythmic drug used in the treatment of life-threatening ventricular tachyarrhythmias."1.30Propafenone-induced drug fever in the absence of agranulocytosis. ( Gerling, BR; Greenberg, ML; Holzberger, PT; O'Rourke, DJ; Palac, RT, 1997)
" Dosage and serum levels of propafenone did not differ whether the patients were treated successfully or not."1.29Clinical experience with propafenone for cardiac arrhythmias in the young. ( Bourgeous, M; Heusch, A; Kramer, HH; Krogmann, ON; Rammos, S, 1994)
"Propafenone is an effective drug for the acute conversion of spontaneous monomorphic sustained ventricular tachycardia, especially in patients without organic heart disease."1.29[The efficacy and safety of intravenous propafenone in the acute treatment of spontaneous sustained ventricular tachycardia]. ( Madrid, AH; Marín-Huerta, E; Mestre, JL; Moro, C; Novo, L, 1994)
"Propafenone is a class Ic anti-arrhythmic agent with mild beta-blocking properties which has recently become available in South Africa."1.29Normal left ventricular function does not protect against propafenone-induced incessant ventricular tachycardia. ( Lawrenson, JB; Millar, RN; Milne, DA, 1993)

Research

Studies (43)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's25 (58.14)18.2507
2000's7 (16.28)29.6817
2010's9 (20.93)24.3611
2020's2 (4.65)2.80

Authors

AuthorsStudies
Cay, S1
Kara, M1
Ozcan, F1
Ozeke, O1
Aksu, T1
Aras, D1
Topaloglu, S1
Basza, M1
Maciejewski, C1
Bojanowicz, W1
Balsam, P1
Grabowski, M1
Mitkowski, P1
Kempa, M1
Kowalski, O1
Kalarus, Z1
Jaguszewski, M1
Lubiński, A1
Daniłowicz-Szymanowicz, L1
Szumowski, Ł1
Sterliński, M1
Kołtowski, Ł1
Bergonti, M1
Assanelli, E1
Agostoni, P1
Rosa, M1
Pappacoda, S1
DʼAnna, C1
Di Mita, O1
Ponticiello, E1
Marzuillo, P1
Tipo, V1
Duan, H1
Lu, Y1
Yan, S1
Qiao, L1
Hua, Y1
Li, Y1
Zhou, K1
Wang, C1
Lin, CY1
Lin, YJ1
Lo, LW1
Chen, YY1
Chong, E1
Chang, SL1
Chung, FP1
Chao, TF1
Hu, YF1
Tuan, TC1
Liao, JN1
Chang, Y1
Chien, KL1
Chiou, CW1
Chen, SA1
Li, X1
Zhang, Y2
Liu, H1
Jiang, H1
Ge, H1
Gilewski, W1
Bednarska, D1
Sinkiewicz, W1
Eroğlu, S1
Ozin, B1
Ozbiçer, S1
Müderrisoğlu, H1
Pino, R1
Sciortino, G1
Polizzi, G1
Hwang, HS1
Hasdemir, C2
Laver, D1
Mehra, D1
Turhan, K1
Faggioni, M1
Yin, H1
Knollmann, BC2
Galimberti, ES1
Musayev, O1
Kehribar, DY1
Kartal, Y1
Can, LH1
Büyükavci, M1
Olgun, H1
Kertmen, B1
Tan, H1
Ceviz, N1
Karaca, M1
Dinckal, MH1
Mykytsey, A1
Bauman, JL1
Razminia, M1
Zheutlin, T1
Wang, T1
Saleem, M1
Leal, S1
Kehoe, RF1
Heusch, A1
Kramer, HH1
Krogmann, ON1
Rammos, S1
Bourgeous, M1
Siebels, J4
Cappato, R2
Rüppel, R2
Schneider, MA2
Kuck, KH4
Kantoch, MJ1
Green, MS1
Tang, AS1
Mestre, JL1
Moro, C1
Madrid, AH1
Novo, L1
Marín-Huerta, E1
Stark, G1
Dhein, S1
Bachernegg, M1
Ziskoven, U1
Zhao, Y1
Klaus, W1
Kickenweiz, E1
Decrinis, M1
Tritthart, HA1
Gutiérrez-Larraya, F1
Jabón, A1
Beaufort-Krol, GC1
Bink-Boelkens, MT1
Libersa, C1
Caron, J1
Broly, F1
Lacroix, D1
Lhermitte, M1
Millar, RN1
Lawrenson, JB1
Milne, DA1
Goedel-Meinen, L1
van Hemel, NM1
Kingma, JH1
Defauw, JJ1
Hoogteijling-van Dusseldorp, E1
Kelder, JC1
Beukema, WP1
Vermeulen, FE1
Stevens, SK1
Haffajee, CI1
Naccarelli, GV1
Schwartz, KM1
Luceri, RM1
Packer, DL1
Rubin, AM1
Kowey, PR1
Gillis, AM1
Wyse, DG1
Mitchell, LB1
Duff, HJ1
Botto, GL1
Bonini, W1
Broffoni, T1
Molteni, S1
Lombardi, R1
Alfieri, G1
Barone, P1
Bernasconi, G1
Ferrari, G1
Oliveira, M1
da Silva, N1
Antunes, E1
Pinto, E1
Cotrim, C1
Pitta, L1
Cacela, D1
Gracias, R1
Antunes, AM1
O'Rourke, DJ1
Palac, RT1
Holzberger, PT1
Gerling, BR1
Greenberg, ML1
Gao, E1
Yang, C1
Li, H1
Duan, Y1
Zhou, Y1
Mastropasqua, F1
Totaro, P1
Massari, F1
Pitzalis, MV1
Rizzon, P1
Pinter, A1
Dorian, P1
Bauer, A1
Schnabel, PA1
Schreiner, KD1
Becker, R1
Voss, F1
Kraft, P1
Senges, J1
Licka, M1
Kübler, W1
Schoels, W1
Takanaka, C1
Nonokawa, M1
Machii, T1
Lee, S1
Kato, H1
Haruna, M1
Yabe, S1
Lombardi, F2
Torzillo, D2
Sandrone, G2
Dalla Vecchia, L2
Cappiello, E2
Finocchiaro, ML1
Bernasconi, R1
Herms, J1
Schneider, M1

Reviews

4 reviews available for propafenone and Tachycardia, Ventricular

ArticleYear
Flecainide in clinical practice.
    Cardiology journal, 2023, Volume: 30, Issue:3

    Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Child; Female; Flecainide; Humans; Pregnancy; Propafeno

2023
[Tachycardias: considerations in childhood in the 90s].
    Anales espanoles de pediatria, 1993, Volume: 39, Issue:6

    Topics: Adenosine; Adolescent; Adult; Amiodarone; Atrial Flutter; Child; Child, Preschool; Electrocardiograp

1993
[Guided anti-arrhythmia therapy by programmed ventricular stimulation. A case of arrhythmogenic dysplasia of the right ventricle].
    Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology, 1997, Volume: 16, Issue:1

    Topics: Adult; Anti-Arrhythmia Agents; Biopsy; Cardiac Pacing, Artificial; Cardiomyopathies; Endocardium; Fe

1997
Intravenous antiarrhythmic agents.
    Current opinion in cardiology, 2001, Volume: 16, Issue:1

    Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Humans; Infusions, Intravenous; Procainamid

2001

Trials

12 trials available for propafenone and Tachycardia, Ventricular

ArticleYear
Observations on the safety and effectiveness of dofetilide in patients with paroxysmal atrial fibrillation and normal left ventricular function.
    Journal of cardiovascular pharmacology and therapeutics, 2007, Volume: 12, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flut

2007
ICD versus drugs in cardiac arrest survivors: preliminary results of the Cardiac Arrest Study Hamburg.
    Pacing and clinical electrophysiology : PACE, 1993, Volume: 16, Issue:3 Pt 2

    Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Death, Sudden, Cardiac; Defibrillators, Implantable

1993
Randomized cross-over evaluation of two adaptive pacing algorithms for the termination of ventricular tachycardia.
    Pacing and clinical electrophysiology : PACE, 1993, Volume: 16, Issue:8

    Topics: Adult; Aged; Aged, 80 and over; Algorithms; Bundle-Branch Block; Cardiac Pacing, Artificial; Defibri

1993
Implantable cardioverter defibrillator compared with antiarrhythmic drug treatment in cardiac arrest survivors (the Cardiac Arrest Study Hamburg).
    American heart journal, 1994, Volume: 127, Issue:4 Pt 2

    Topics: Amiodarone; Anti-Arrhythmia Agents; Death, Sudden, Cardiac; Defibrillators, Implantable; Female; Hea

1994
Preliminary results of the Cardiac Arrest Study Hamburg (CASH). CASH Investigators.
    The American journal of cardiology, 1993, Nov-26, Volume: 72, Issue:16

    Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Death, Sudden, Cardiac; Defibrillators, Implantable

1993
Continuation of antiarrhythmic drugs, or arrhythmia surgery after multiple drug failures. A randomized trial in the treatment of postinfarction ventricular tachycardia.
    European heart journal, 1996, Volume: 17, Issue:4

    Topics: Adult; Aged; Anti-Arrhythmia Agents; Female; Flecainide; Humans; Male; Middle Aged; Propafenone; Sot

1996
Effects of oral propafenone on defibrillation and pacing thresholds in patients receiving implantable cardioverter-defibrillators. Propafenone Defibrillation Threshold Investigators.
    Journal of the American College of Cardiology, 1996, Volume: 28, Issue:2

    Topics: Administration, Oral; Aged; Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Defibrillators, Impl

1996
Conversion of recent onset atrial fibrillation with single loading oral dose of propafenone: is in-hospital admission absolutely necessary?
    Pacing and clinical electrophysiology : PACE, 1996, Volume: 19, Issue:11 Pt 2

    Topics: Administration, Oral; Age Factors; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Function; Atr

1996
Preliminary study of the effects of metoprolol and propafenone on ventricular arrhythmia with positive ventricular late potential.
    Chinese medical journal, 1997, Volume: 110, Issue:9

    Topics: Adult; Anti-Arrhythmia Agents; Electrocardiography; Female; Humans; Male; Metoprolol; Middle Aged; P

1997
[Double-blind randomized placebo-controlled study of the effects of slow release and immediate release forms of propafenone in patients ventricular extrasystole symptoms].
    Cardiologia (Rome, Italy), 1998, Volume: 43, Issue:6

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Cardiac Complexes, Premature; Do

1998
A multicentre, randomized trial on the benefit/risk profile of amiodarone, flecainide and propafenone in patients with cardiac disease and complex ventricular arrhythmias. Antiarrhythmic Drug Evaluation Group (A.D.E.G.).
    European heart journal, 1992, Volume: 13, Issue:9

    Topics: Amiodarone; Cardiomyopathy, Dilated; Cardiomyopathy, Hypertrophic; Dose-Response Relationship, Drug;

1992
[Prospective long-term ECG study of 100 patients surviving sudden cardiac death].
    Zeitschrift fur Kardiologie, 1992, Volume: 81, Issue:12

    Topics: Adult; Aged; Amiodarone; Death, Sudden, Cardiac; Defibrillators, Implantable; Electrocardiography, A

1992

Other Studies

27 other studies available for propafenone and Tachycardia, Ventricular

ArticleYear
Propafenone use in coronary artery disease patients undergoing atrial fibrillation ablation.
    Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing, 2022, Volume: 65, Issue:2

    Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Coronary Artery Disease; Death, Sudden, Car

2022
The Wrong Drug That Led to the Right Diagnosis.
    Circulation, 2019, 11-05, Volume: 140, Issue:19

    Topics: Action Potentials; Aged, 80 and over; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; D

2019
Ventricular Tachycardia Induced by Propafenone Intoxication in a Pediatric Patient.
    Pediatric emergency care, 2019, Volume: 35, Issue:9

    Topics: Administration, Intravenous; Anti-Arrhythmia Agents; Child, Preschool; Electrocardiography; Humans;

2019
A delayed diagnosis of catecholaminergic polymorphic ventricular tachycardia with a mutant of RYR2 at c.7580T>G for 6 years in a 9-year-old child.
    Medicine, 2018, Volume: 97, Issue:16

    Topics: Amiodarone; Anti-Arrhythmia Agents; Child; Death, Sudden, Cardiac; Delayed Diagnosis; Electrocardiog

2018
Factors predisposing to ventricular proarrhythmia during antiarrhythmic drug therapy for atrial fibrillation in patients with structurally normal heart.
    Heart rhythm, 2015, Volume: 12, Issue:7

    Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Echocardiography; Electrocardiography; Female; He

2015
Efficacy of Intravenous Sotalol for Treatment of Incessant Tachyarrhythmias in Children.
    The American journal of cardiology, 2017, 05-01, Volume: 119, Issue:9

    Topics: Adolescent; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Child; Child, Preschool; Dr

2017
[Life-threatening ventricular arrhythmia during simultaneous administration of propafenone and sotatol].
    Kardiologia polska, 2009, Volume: 67, Issue:8

    Topics: Anti-Arrhythmia Agents; Drug Therapy, Combination; Electrocardiography; Humans; Male; Middle Aged; P

2009
A case of myotonic dystrophy presenting with ventricular tachycardia and atrial fibrillation.
    Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir, 2009, Volume: 37, Issue:5

    Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Defibrillators, Implantable

2009
Brugada-like phenomenon, induced by intravenous propafenone, in a patient with idiopathic fascicular ventricular tachycardia.
    Journal of cardiovascular medicine (Hagerstown, Md.), 2013, Volume: 14, Issue:5

    Topics: Administration, Intravenous; Anti-Arrhythmia Agents; Brugada Syndrome; Electrocardiography; Heart Co

2013
Inhibition of cardiac Ca2+ release channels (RyR2) determines efficacy of class I antiarrhythmic drugs in catecholaminergic polymorphic ventricular tachycardia.
    Circulation. Arrhythmia and electrophysiology, 2011, Volume: 4, Issue:2

    Topics: Analysis of Variance; Animals; Anti-Arrhythmia Agents; Calcium Channel Blockers; Calsequestrin; Defi

2011
Efficacy and potency of class I antiarrhythmic drugs for suppression of Ca2+ waves in permeabilized myocytes lacking calsequestrin.
    Journal of molecular and cellular cardiology, 2011, Volume: 51, Issue:5

    Topics: Animals; Anti-Arrhythmia Agents; Calcium; Calcium Signaling; Calsequestrin; Cell Membrane Permeabili

2011
Chronic cough and tachycardia-induced cardiomyopathy in a patient with idiopathic frequent, monomorphic premature ventricular contractions.
    Pacing and clinical electrophysiology : PACE, 2013, Volume: 36, Issue:5

    Topics: Aged; Anti-Arrhythmia Agents; Cardiomyopathies; Chronic Disease; Cough; Female; Humans; Propafenone;

2013
Ventricular tachycardia as a presenting symptom in a child with thrombotic thrombocytopenic purpura.
    Thrombosis and haemostasis, 2004, Volume: 91, Issue:1

    Topics: Adolescent; Anti-Arrhythmia Agents; Diagnosis, Differential; Electrocardiography; Female; Humans; Me

2004
Monomorphic and propafenone-induced polymorphic ventricular tachycardia in Brugada syndrome: a case report.
    Acta cardiologica, 2006, Volume: 61, Issue:4

    Topics: Adult; Ajmaline; Anti-Arrhythmia Agents; Brugada Syndrome; Bundle-Branch Block; Defibrillators, Impl

2006
Clinical experience with propafenone for cardiac arrhythmias in the young.
    European heart journal, 1994, Volume: 15, Issue:8

    Topics: Administration, Oral; Adolescent; Arrhythmias, Cardiac; Atrial Flutter; Cardiac Complexes, Premature

1994
[The efficacy and safety of intravenous propafenone in the acute treatment of spontaneous sustained ventricular tachycardia].
    Revista espanola de cardiologia, 1994, Volume: 47, Issue:7

    Topics: Acute Disease; Aged; Chi-Square Distribution; Drug Evaluation; Electrocardiography; Female; Humans;

1994
Frequency-dependent effects of propafenone decrease with duration of ventricular tachycardia in isolated guinea pig hearts.
    European journal of pharmacology, 1994, Feb-11, Volume: 252, Issue:3

    Topics: Action Potentials; Animals; Electrocardiography; Female; Guinea Pigs; Heart Conduction System; In Vi

1994
Oral propafenone as treatment for incessant supraventricular and ventricular tachycardia in children.
    The American journal of cardiology, 1993, Nov-15, Volume: 72, Issue:15

    Topics: Administration, Oral; Adolescent; Child; Child, Preschool; Female; Humans; Infant; Infant, Newborn;

1993
Interaction of propafenone and mexiletine.
    Journal of the American College of Cardiology, 1993, Volume: 22, Issue:7

    Topics: Drug Interactions; Drug Therapy, Combination; Humans; Mexiletine; Propafenone; Tachycardia, Ventricu

1993
Normal left ventricular function does not protect against propafenone-induced incessant ventricular tachycardia.
    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 1993, Volume: 83, Issue:4

    Topics: Adult; Electrocardiography; Humans; Male; Propafenone; Tachycardia, Ventricular; Ventricular Functio

1993
[Syncope in Lown IVb ventricular arrhythmias and mitral valve prolapse].
    Fortschritte der Medizin, 1993, Jan-20, Volume: 111, Issue:1-2

    Topics: Adult; Electrocardiography, Ambulatory; Humans; Male; Mitral Valve Prolapse; Propafenone; Syncope; T

1993
Propafenone pharmacokinetics and pharmacodynamics in patients with sustained ventricular tachycardia.
    The American journal of cardiology, 1996, Sep-01, Volume: 78, Issue:5

    Topics: Aged; Anti-Arrhythmia Agents; Humans; Infusions, Intravenous; Male; Middle Aged; Myocardium; Propafe

1996
Propafenone-induced drug fever in the absence of agranulocytosis.
    Clinical cardiology, 1997, Volume: 20, Issue:7

    Topics: Agranulocytosis; Anti-Arrhythmia Agents; Diagnosis, Differential; Fever; Humans; Leukocyte Count; Ma

1997
Effects of propafenone on anisotropic conduction properties within the three-dimensional structure of the canine ventricular wall.
    Basic research in cardiology, 2001, Volume: 96, Issue:2

    Topics: Animals; Anisotropy; Anti-Arrhythmia Agents; Dogs; Heart; Heart Ventricles; Membrane Potentials; Myo

2001
Mexiletine and propafenone: a comparative study of monotherapy, low, and full dose combination therapy.
    Pacing and clinical electrophysiology : PACE, 1992, Volume: 15, Issue:11 Pt 2

    Topics: Arrhythmias, Cardiac; Cardiac Complexes, Premature; Drug Therapy, Combination; Electrocardiography;

1992
Autonomic effects of antiarrhythmic drugs and their importance.
    European heart journal, 1992, Volume: 13 Suppl F

    Topics: Adult; Autonomic Nervous System; Cardiac Complexes, Premature; Electrocardiography; Female; Flecaini

1992
Beta-blocking effect of propafenone based on spectral analysis of heart rate variability.
    The American journal of cardiology, 1992, Oct-15, Volume: 70, Issue:11

    Topics: Adrenergic beta-Antagonists; Electrocardiography; Heart Rate; Humans; Posture; Propafenone; Receptor

1992